Small-firm drugs are valued at an average of $2.16 billion, with preclinical risk-adjusted net value of $50 million and discovery-stage expected cost of $38 million, derived from market responses to announcements.
Key Cost Drivers of Pharmaceutical Clinical Trials in the United States
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
econ.GN 1years
2022 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Valuing Pharmaceutical Drug Innovations
Small-firm drugs are valued at an average of $2.16 billion, with preclinical risk-adjusted net value of $50 million and discovery-stage expected cost of $38 million, derived from market responses to announcements.